Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 1
1(33.3%)
Phase 2
1(33.3%)
3Total
N/A(1)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07548515Not Yet Recruiting

Understanding the Relationship of Body Composition and Metabolism in Adult and Older Filipino Endurance and Strength Athletes in the Philippines

Role: collaborator

NCT05701735Not ApplicableRecruiting

Decision Aid for Chemotherapy in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer

Role: collaborator

NCT05210270Phase 1Not Yet Recruiting

HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy

Role: collaborator

NCT04849637Phase 2Unknown

Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients

Role: collaborator

All 4 trials loaded